Resultados de la búsqueda 321-330 of 12120 for B cell lymphomas
The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...
People who seek care at Mayo Clinic have access to all the treatment options for follicular lymphoma. These include antibody therapy, immunotherapy, CAR-T cell ...
... Lymphoma, (RR NHL) and a Dose Expansion Phase (Part B) of CA-4948 in patients with RR NHL with and without myeloid differentiation primary response 88 ...
... B]. This Phase 3 study is designed to evaluate ... cell lymphoma that has come back or does not respond to treatment. ... A virus, called VSV-hIFNbeta-NIS, which ...
A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma. Rochester, Minn ...
... Lymphoma (SLL). Rochester, Minn., Jacksonville ... Lymphoma (SLL). ... Durvalumab is FDA approved for treatment in lung cancers including non-small cell lung cancer ...
Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by ...
Mostrando 1-1 de doctores disponibles. Inicial del apellido: O. Madeleine B. O'Keefe, M.D.. hematólogo / oncólogo pediátrico.
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?